Alkem Labs Receives GST Demand Order of ₹2.17 Crore
Alkem Laboratories received a GST demand order from Lucknow CGST of ₹1.08 crore, with an equal penalty and interest, totaling ₹2.17 crore for FY19-FY21. The company disputes the demand, citing excess Input Tax Credit, and plans to appeal.
The company explicitly states that there is no material impact on its financial, operational, or other activities, and the amount is not considered material in the context of the company's overall financials.
The company has received a GST demand order, which is a negative event. However, the company believes there is no material impact and plans to contest the order, mitigating the immediate negative sentiment.
Alkem Laboratories Limited has received an order from the Deputy Commissioner, CGST & Central Excise Division – I, Lucknow, under the Goods and Services Tax Act, 2017. The order pertains to the period 2018-2019 to 2020-2021 and demands GST of ₹1,08,81,393 along with an equal amount of interest and penalty, totaling ₹2,17,62,786.
The demand order primarily alleges excess availment of Input Tax Credit. The company has stated that it disagrees with the order and intends to contest it by filing an appeal. Alkem Laboratories Limited has indicated that there is no material impact on its financial, operational, or other activities.
The order was received by the company on December 31, 2025. This disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Alkem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under regulatory impact. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alkem Laboratories Limited. Read the original for the full detail.